Yunaconitine |
A diterpenoid alkaloid with diverse biological activities; active against… |
10 mg |
34127-10 |
More Info
|
Yunaconitine |
A diterpenoid alkaloid with diverse biological activities; active against… |
25 mg |
34127-25 |
More Info
|
Yunaconitine |
A diterpenoid alkaloid with diverse biological activities; active against… |
5 mg |
34127-5 |
More Info
|
YVAD-CHO (trifluoroacetate salt) |
A caspase-1 / ICE inhibitor; prevents ICE-like and CPP32-like proteinase a… |
1 mg |
27420-1 |
More Info
|
YVAD-CHO (trifluoroacetate salt) |
A caspase-1 / ICE inhibitor; prevents ICE-like and CPP32-like proteinase a… |
5 mg |
27420-5 |
More Info
|
YW1128 |
An inhibitor of Wnt signaling (IC50 = 4.1 nM); decreases lipid accumulatio… |
1 mg |
27450-1 |
More Info
|
YW1128 |
An inhibitor of Wnt signaling (IC50 = 4.1 nM); decreases lipid accumulatio… |
10 mg |
27450-10 |
More Info
|
YW1128 |
An inhibitor of Wnt signaling (IC50 = 4.1 nM); decreases lipid accumulatio… |
5 mg |
27450-5 |
More Info
|
YW1159 |
An inhibitor of Wnt signaling (IC50 = 1.2 nM); not cytotoxic to HEK293 cel… |
1 mg |
27451-1 |
More Info
|
YW1159 |
An inhibitor of Wnt signaling (IC50 = 1.2 nM); not cytotoxic to HEK293 cel… |
10 mg |
27451-10 |
More Info
|
YW1159 |
An inhibitor of Wnt signaling (IC50 = 1.2 nM); not cytotoxic to HEK293 cel… |
5 mg |
27451-5 |
More Info
|
YYA-021 |
A small molecule CD4 mimetic; inhibits gp120 and CD4 interaction, preventi… |
1 mg |
22915-1 |
More Info
|
YYA-021 |
A small molecule CD4 mimetic; inhibits gp120 and CD4 interaction, preventi… |
10 mg |
22915-10 |
More Info
|
YYA-021 |
A small molecule CD4 mimetic; inhibits gp120 and CD4 interaction, preventi… |
25 mg |
22915-25 |
More Info
|
YYA-021 |
A small molecule CD4 mimetic; inhibits gp120 and CD4 interaction, preventi… |
5 mg |
22915-5 |
More Info
|
YZ9 |
A potent inhibitor of the glycolysis enzyme PFKFB3, with an IC50 value of… |
10 mg |
15352-10 |
More Info
|
YZ9 |
A potent inhibitor of the glycolysis enzyme PFKFB3, with an IC50 value of… |
100 mg |
15352-100 |
More Info
|
YZ9 |
A potent inhibitor of the glycolysis enzyme PFKFB3, with an IC50 value of… |
5 mg |
15352-5 |
More Info
|
YZ9 |
A potent inhibitor of the glycolysis enzyme PFKFB3, with an IC50 value of… |
50 mg |
15352-50 |
More Info
|
Z944 |
A T-type calcium channel inhibitor (IC50s = 0.050-0.160 µM for human… |
1 mg |
27679-1 |
More Info
|
Z944 |
A T-type calcium channel inhibitor (IC50s = 0.050-0.160 µM for human… |
10 mg |
27679-10 |
More Info
|
Z944 |
A T-type calcium channel inhibitor (IC50s = 0.050-0.160 µM for human… |
25 mg |
27679-25 |
More Info
|
Z944 |
A T-type calcium channel inhibitor (IC50s = 0.050-0.160 µM for human… |
5 mg |
27679-5 |
More Info
|
Z-AEVD-FMK |
An irreversible inhibitor of caspase-10 and related caspases that at 10 &m… |
1 mg |
14987-1 |
More Info
|
Z-AEVD-FMK |
An irreversible inhibitor of caspase-10 and related caspases that at 10 &m… |
5 mg |
14987-5 |
More Info
|
Z-AEVD-FMK |
An irreversible inhibitor of caspase-10 and related caspases that at 10 &m… |
500 µg |
14987-500 |
More Info
|
Zafirlukast |
A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… |
10 mg |
10008282-10 |
More Info
|
Zafirlukast |
A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… |
100 mg |
10008282-100 |
More Info
|
Zafirlukast |
A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… |
1000 mg |
10008282-1 |
More Info
|
Zafirlukast |
A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… |
500 mg |
10008282-500 |
More Info
|
(Z-Ala-Ala-Ala-Ala)2Rh110 |
A sensitive fluorogenic elastase substrate that is selectively cleaved by… |
1 mg |
11675-1 |
More Info
|
(Z-Ala-Ala-Ala-Ala)2Rh110 |
A sensitive fluorogenic elastase substrate that is selectively cleaved by… |
10 mg |
11675-10 |
More Info
|
(Z-Ala-Ala-Ala-Ala)2Rh110 |
A sensitive fluorogenic elastase substrate that is selectively cleaved by… |
5 mg |
11675-5 |
More Info
|
Zalcitabine |
A NRTI; reduces the replication of laboratory-adapted and clinical isolate… |
100 mg |
16019-100 |
More Info
|
Zalcitabine |
A NRTI; reduces the replication of laboratory-adapted and clinical isolate… |
25 mg |
16019-25 |
More Info
|
Zalcitabine |
A NRTI; reduces the replication of laboratory-adapted and clinical isolate… |
250 mg |
16019-250 |
More Info
|
Zalcitabine |
A NRTI; reduces the replication of laboratory-adapted and clinical isolate… |
500 mg |
16019-500 |
More Info
|
Zaltoprofen |
An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… |
10 mg |
14662-10 |
More Info
|
Zaltoprofen |
An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… |
100 mg |
14662-100 |
More Info
|
Zaltoprofen |
An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… |
250 mg |
14662-250 |
More Info
|
Zaltoprofen |
An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… |
50 mg |
14662-50 |
More Info
|
Zamifenacin (fumarate) |
An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… |
1 mg |
32848-1 |
More Info
|
Zamifenacin (fumarate) |
An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… |
10 mg |
32848-10 |
More Info
|
Zamifenacin (fumarate) |
An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… |
5 mg |
32848-5 |
More Info
|
Zanamivir |
An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… |
1 mg |
15123-1 |
More Info
|
Zanamivir |
An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… |
10 mg |
15123-10 |
More Info
|
Zanamivir |
An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… |
25 mg |
15123-25 |
More Info
|
Zanamivir |
An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… |
5 mg |
15123-5 |
More Info
|
Zanamivir-13C,15N2 (hydrate) |
An internal standard for the quantification of zanamivir by GC- or LC-MS |
250 µg |
30733-250 |
More Info
|
Zanubrutinib |
A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… |
1 mg |
28924-1 |
More Info
|
Zanubrutinib |
A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… |
10 mg |
28924-10 |
More Info
|
Zanubrutinib |
A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… |
25 mg |
28924-25 |
More Info
|
Zanubrutinib |
A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… |
5 mg |
28924-5 |
More Info
|
Zapnometinib |
A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… |
10 mg |
38517-10 |
More Info
|
Zapnometinib |
A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… |
25 mg |
38517-25 |
More Info
|
Zapnometinib |
A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… |
5 mg |
38517-5 |
More Info
|
Zapnometinib |
A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… |
50 mg |
38517-50 |
More Info
|
Zaprinast |
A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… |
10 mg |
10010421-10 |
More Info
|
Zaprinast |
A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… |
100 mg |
10010421-100 |
More Info
|
Zaprinast |
A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… |
250 mg |
10010421-250 |
More Info
|
Zaprinast |
A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… |
50 mg |
10010421-50 |
More Info
|
Zaragozic Acid A |
A reversible competitive inhibitor of squalene synthase (Ki = 78 pM in vit… |
1 mg |
17452-1 |
More Info
|
Zaragozic Acid A |
A reversible competitive inhibitor of squalene synthase (Ki = 78 pM in vit… |
5 mg |
17452-5 |
More Info
|
Zardaverine |
A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… |
1 mg |
29685-1 |
More Info
|
Zardaverine |
A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… |
10 mg |
29685-10 |
More Info
|
Zardaverine |
A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… |
25 mg |
29685-25 |
More Info
|
Zardaverine |
A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… |
5 mg |
29685-5 |
More Info
|
Z-Asp-CH2-DCB |
A pan-caspase inhibitor that blocks apoptosis, prevents the production of… |
10 mg |
15143-10 |
More Info
|
Z-Asp-CH2-DCB |
A pan-caspase inhibitor that blocks apoptosis, prevents the production of… |
25 mg |
15143-25 |
More Info
|
Z-Asp-CH2-DCB |
A pan-caspase inhibitor that blocks apoptosis, prevents the production of… |
5 mg |
15143-5 |
More Info
|
Z-Asp-CH2-DCB |
A pan-caspase inhibitor that blocks apoptosis, prevents the production of… |
50 mg |
15143-50 |
More Info
|
Zatebradine (hydrochloride) |
Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… |
10 mg |
18608-10 |
More Info
|
Zatebradine (hydrochloride) |
Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… |
25 mg |
18608-25 |
More Info
|
Zatebradine (hydrochloride) |
Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… |
5 mg |
18608-5 |
More Info
|
Zatebradine (hydrochloride) |
Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… |
50 mg |
18608-50 |
More Info
|